Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Impact of KIR/HLA Incompatibilities after Posttransplant Cyclophosphamide Based T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation

Sarah Lindner, MD, Tobias Berg, MD, Christian Seidel, Franziska Kalensee, Michael A. Rieger, Hubert Serve, MD, Gesine Bug, Joachim Schwaeble, Evelyn Ullrich, MD

Blood (2019) 134 (Supplement_1): 3340.

https://doi.org/10.1182/blood-2019-125243

Published: 2019

Journal Articles

Interferon Regulatory Factor 4 Is a Key Factor in Regulation of T helper Cell Polarization in Graft-Versus-Host Disease

Jochen T Frueh, MSc, BSc, Bushra Rais, PhD, Daniele Yumi Sunaga-Franze, Katja Stein, Sascha Sauer, PhD, Andreas G Chiocchetti, PhD, Michael Lohoff, PhD, Evelyn Ullrich, MD

Blood (2018) 132 (Supplement 1): 3313.

https://doi.org/10.1182/blood-2018-99-116151

Published: 2018

Journal Articles

Neutralizing IL-2 Early after HCT Specifically Prevents Expansion of Donor GM-CSF-Producing CD4 + T Cells That Initiate Acute Gut Gvhd

Qingxiao Song, MD, Xiaoning Wang, MD, Paul J Martin, MD, Yuanzhong Chen, MD PhD, Defu Zeng, MD

Blood (2018) 132 (Supplement 1): 2030.

https://doi.org/10.1182/blood-2018-99-119966

Published: 2018

Journal Articles

Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis

Renato Tavares, MD, Giuseppe A. Palumbo, MD, Philipp Le Coutre, MD, Francesca Palandri, MD PhD, Haifa Kathrin Al-Ali, MD, Bruno Martino, MD, Anna Marina Liberati, MD, Jose Grasa Ullrich, MD, Massimo Breccia, MD, David Brittain, MD, Lynda Foltz, MD FRCP, Martin Griesshammer, MD, Pia Raanani, MD, Vikas Gupta, MD FRCP, FRCPath, Pilar Giraldo, MD PhD, Jagannath Ghosh, Bayane Tannir, Julian Perez Ronco, MD MBA, Alessandro M. Vannucchi, MD

Blood (2015) 126 (23): 2799.

https://doi.org/10.1182/blood.V126.23.2799.2799

Published: 2015

Journal Articles

Tissue Factor Pathway Inhibitor Isoforms of Macro- and Microvascular Endothelial Cells

Michael Dockal, PhD, Robert Pachlinger, PhD, Angelina Baldin-Stoyanova, Fabian Knofl, Nadja Ullrich, Friedrich Scheiflinger, PhD

Blood (2014) 124 (21): 4167.

https://doi.org/10.1182/blood.V124.21.4167.4167

Published: 2014

NARROW

Impact of KIR/HLA Incompatibilities after Posttransplant Cyclophosphamide Based T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation

Interferon Regulatory Factor 4 Is a Key Factor in Regulation of T helper Cell Polarization in Graft-Versus-Host Disease

Neutralizing IL-2 Early after HCT Specifically Prevents Expansion of Donor GM-CSF-Producing CD4 + T Cells That Initiate Acute Gut Gvhd

Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis

Tissue Factor Pathway Inhibitor Isoforms of Macro- and Microvascular Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

Impact of KIR/HLA Incompatibilities after Posttransplant Cyclophosphamide Based T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation

Interferon Regulatory Factor 4 Is a Key Factor in Regulation of T helper Cell Polarization in Graft-Versus-Host Disease

Neutralizing IL-2 Early after HCT Specifically Prevents Expansion of Donor GM-CSF-Producing CD4 + T Cells That Initiate Acute Gut Gvhd

Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis

Tissue Factor Pathway Inhibitor Isoforms of Macro- and Microvascular Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only